Anti-HGFA Inhibitor 2 antibody [EPR6283(2)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal HGFA Inhibitor 2 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 4 publications.
View Alternative Names
HAI2, KOP, SPINT2, Kunitz-type protease inhibitor 2, Hepatocyte growth factor activator inhibitor type 2, Placental bikunin, HAI-2
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-HGFA Inhibitor 2 antibody [EPR6283(2)] (AB128926)
ab128926, at 1/250 dilution, staining HGFA Inhibitor 2 in MCF-7 cells by Immunofluorescence.
- WB
Lab
Western blot - Anti-HGFA Inhibitor 2 antibody [EPR6283(2)] (AB128926)
Blocking buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-HGFA Inhibitor 2 antibody [EPR6283(2)] (ab128926) at 1/1000 dilution
Lane 1:
Caco-2 (Human colorectal adenocarcinoma epithelial cell) whole cell lysate at 15 µg
Lane 2:
MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
PC-3 (Human prostate adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
BxPC-3 (Human pancreas adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 5:
MDA-MB-435S (Human mammary gland ductal carcinoma melanocyte) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 28 kDa
Observed band size: 34 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-HGFA Inhibitor 2 antibody [EPR6283(2)] (AB128926)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (1)
-
Anti-HGFA Inhibitor 2 antibody [EPR6283(2)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HGFA Inhibitor 2 is involved in the control of protease-mediated signaling pathways by functioning as a member of a protease inhibitor complex. It plays a role in modulating the activity of proteolytic enzymes which influence tissue remodeling cell growth and angiogenesis. By inhibiting HGFA HAI-2 regulates the conversion of inactive hepatocyte growth factor (HGF) into its active form therefore controlling processes that are important for epithelial cell dynamics.
Pathways
HGFA Inhibitor 2 contributes to the HGF/c-Met signaling pathway and impacts the plasminogen activation system. Through the regulation of HGFA HAI-2 inadvertently influences the activation of c-Met a receptor tyrosine kinase. This interaction is key for numerous processes including cell proliferation motility and morphogenesis. Additionally by affecting the plasminogen activation cascade it helps to modulate extracellular matrix degradation and cellular migration through its association with proteins like uPA and plasminogen.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Oncotarget 13:1175-1186 PubMed36268559
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 10:435 PubMed31164631
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 23:1562-1571 PubMed30484958
2018
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells and development 23:1109-20 PubMed24410667
2014
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com